by rdbiomed | Feb 22, 2021 | Company Updates
Peptest and the importance of salivary pepsin detection was put under the spotlight at a forum in China, attended by our distributor Maxhealth. The 13th China Cough Forum and the 13th National Class on Chronic Cough and Difficult and Rare Diseases took place in... 
by rdbiomed | Jan 8, 2021 | Company Updates
Professor Peter Dettmar has provided insight into the diagnosis and treatment of reflux disease to a virtual conference of key opinion leaders in China. His presentation featured at the virtual 2020 Annual Meeting of the Gastroesophageal Reflux Multidisciplinary... 
by rdbiomed | Sep 14, 2020 | Company Updates
Peptest could prove useful during the current Covid-19 pandemic when access to clinics and more complex clinical diagnostic procedures is restricted or delayed. Many non-essential medical procedures have been postponed or cancelled during the Covid-19 pandemic, with... 
by rdbiomed | May 26, 2020 | Company Updates
We’re delighted to share the news that Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’. Respiratory Technology Corporation (Restech) is a leader in engineering world... 
by rdbiomed | May 18, 2020 | Company Updates
We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus pandemic we made the decision to temporarily suspend testing due to restrictions on staff movements and concerns... 
by rdbiomed | Mar 26, 2020 | Company Updates
In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will be working from home and following all of the government guidelines for the near future. We are temporarily suspending...
Recent Comments